(Q39337417)

11 September 2017

title

Plasmablastic lymphoma phenotype is determined by genetic alterations in MYC and PRDM1. (English)

1 reference

11 September 2017

0 references

plasmablastic lymphoma

1 reference

inferred from title

author

Santiago Montes-Moreno

1

1 reference

11 September 2017

12

1 reference

11 September 2017

8

Ana Batlle

1 reference

Sonia Gonzalez de Villambrosía

11 September 2017

4

object named as

Sonia Gonzalez de Villambrosía

1 reference

Socorro Maria Rodriguez-Pinilla

11 September 2017

7

object named as

María Rodriguez-Pinilla

1 reference

11 September 2017

Laura Cereceda-Company

9

object named as

Laura Cereceda-Company

1 reference

11 September 2017

11

Carmen Almaraz

1 reference

11 September 2017

author name string

Nerea Martinez-Magunacelaya

2

1 reference

11 September 2017

Tomás Zecchini-Barrese

3

1 reference

11 September 2017

Emma Linares

5

1 reference

11 September 2017

Tamara Ranchal

6

1 reference

11 September 2017

Jose Bernardo Revert-Arce

10

1 reference

11 September 2017

publication date

30 September 2016

1 reference

11 September 2017

1 reference

11 September 2017

volume

30

1 reference

11 September 2017

issue

1

1 reference

11 September 2017

page(s)

85-94

1 reference

https://scigraph.springernature.com/pub.10.1038/modpathol.2016.162

11 September 2017

exact match

0 references

cites work

The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2016.162

Aggressive large B-cell lymphoma with plasma cell differentiation: immunohistochemical characterization of plasmablastic lymphoma and diffuse large B-cell lymphoma with partial plasmablastic phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2016.162

Clinicopathologic comparison of plasmablastic lymphoma in HIV-positive, immunocompetent, and posttransplant patients: single-center series of 25 cases and meta-analysis of 277 reported cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2016.162

The biology and treatment of plasmablastic lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2016.162

Diffuse large B-cell lymphomas with plasmablastic differentiation represent a heterogeneous group of disease entities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2016.162

Gene expression analysis of plasmablastic lymphoma identifies downregulation of B-cell receptor signaling and additional unique transcriptional programs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2016.162

ALK-positive large B-cell lymphomas express a terminal B-cell differentiation program and activated STAT3 but lack MYC rearrangements.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2016.162

Stage, age, and EBV status impact outcomes of plasmablastic lymphoma patients: a clinicopathologic analysis of 61 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2016.162

Inactivation of the PRDM1/BLIMP1 gene in diffuse large B cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2016.162

Blimp-1 orchestrates plasma cell differentiation by extinguishing the mature B cell gene expression program

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2016.162

Expression pattern of XBP1(S) in human B-cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2016.162

Repression of c-myc transcription by Blimp-1, an inducer of terminal B cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2016.162

Analysis of the coding genome of diffuse large B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2016.162

Genetic heterogeneity of diffuse large B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2016.162

Mutational analysis of PRDM1 indicates a tumor-suppressor role in diffuse large B-cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2016.162

BLIMP1 is a tumor suppressor gene frequently disrupted in activated B cell-like diffuse large B cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2016.162

Chromosomal imbalances and partial uniparental disomies in primary central nervous system lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2016.162

SnapShot: diffuse large B cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2016.162

Diffuse large B-cell lymphoma patient-derived xenograft models capture the molecular and biological heterogeneity of the disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2016.162

Tissue microarray technology for high-throughput molecular profiling of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2016.162

Integrative genomics viewer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2016.162

Diffuse Large B-cell Lymphomas of Immunoblastic Type Are a Major Reservoir for MYC-IGH Translocations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2016.162

Transcriptional repression by blimp-1 (PRDI-BF1) involves recruitment of histone deacetylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2016.162

Plasmablastic lymphoma of the elderly: a clinicopathological comparison with age-related Epstein-Barr virus-associated B cell lymphoproliferative disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2016.162

Clinical and pathological differences between human immunodeficiency virus-positive and human immunodeficiency virus-negative patients with plasmablastic lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2016.162

Identification of a functionally impaired positive regulatory domain I binding factor 1 transcription repressor in myeloma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2016.162

Double-hit B-cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2016.162

Transformation of follicular lymphoma to plasmablastic lymphoma with c-myc gene rearrangement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2016.162

Blimp-1-dependent repression of Pax-5 is required for differentiation of B cells to immunoglobulin M-secreting plasma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2016.162

Diagnosis of 'double hit' diffuse large B-cell lymphoma and B-cell lymphoma, unclassifiable, with features intermediate between DLBCL and Burkitt lymphoma: when and how, FISH versus IHC.

21 January 2018

1 reference

12 December 2020

Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection

1 reference

12 December 2020

Significance of PRDM1beta expression as a prognostic marker in diffuse large B-cell lymphomas

1 reference

12 December 2020

Positive regulatory domain I binding factor 1 silences class II transactivator expression in multiple myeloma cells

1 reference

12 December 2020

Novel BLIMP1/PRDM1 gene mutations in B-cell lymphoma

1 reference

12 December 2020

CD20-negative large-cell lymphoma with plasmablastic features: a clinically heterogenous spectrum in both HIV-positive and -negative patients

1 reference

12 December 2020

IG/MYC rearrangements are the main cytogenetic alteration in plasmablastic lymphomas

1 reference

12 December 2020

Plasmablastic lymphoma with MYC translocation: evidence for a common pathway in the generation of plasmablastic features

1 reference

12 December 2020

Recurrent Inactivation of the PRDM1 Gene in Primary Central Nervous System Lymphoma

1 reference

12 December 2020

10.1038/MODPATHOL.2016.162

Identifiers

DOI

1 reference

11 September 2017

1 reference